Medicine
Fludeoxyglucose f-18 240 mCi/mL injection
Fludeoxyglucose f-18 240 mCi/mL injection is a generic prescription medicine for intravenous use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Storage as on the product label
Key facts
- Active ingredient (INN)
- Fludeoxyglucose f-18
- Brand
- Sold under the generic name
- Strength
- 240 mCi/mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 30 mL
- Manufacturer
- Mayo Clinic
- Origin register
- US FDA, United States
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- V09IX04 Fludeoxyglucose f-18
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 5 August 2013
- Identifiers
- DailyMed set ID 153b650d-7b69-4880-a72a-a5f13059d248NDC 52670-551Application ANDA203612
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 mL in 1 vial, multi-dose | 52670-551-30 | Mayo Clinic | 5 August 2013 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 19 August 1994 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Fludeoxyglucose f-18
Clinical summary
Fludeoxyglucose f-18 is a radioactive diagnostic agent indicated for positron emission tomography (PET) imaging in settings, among other approved uses. It is available as injection for intravenous use. MedsAcross supplies Fludeoxyglucose f-18 for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Fludeoxyglucose f-18For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Fludeoxyglucose F18 prescribing information (The Feinstein Institute for Medical Research) · U.S. National Library of Medicine, DailyMed
Need Fludeoxyglucose f-18 240 mCi/mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.